 |
|
|
|
 |
|
Table 1
|
|
Patient
characteristics and treatment data.
|
|
Study cohort
|
|
1
|
2
|
3
|
|
Number
(male)
|
9
(6)
|
10
(6)
|
8
(5)
|
|
Median
age in years (range)
|
43
(25-69)
|
51
(40-68)
|
46
(34-67)
|
|
Median
KPS (range)
|
100
(90-100)
|
90
(70-100)
|
100
(90-100)
|
|
No.
of patients with disease stage:
|
II
|
1
|
0
|
2
|
III
|
2
|
1
|
0
|
IV:
|
Visceral
|
5
|
6
|
3
|
|
Non-visceral
|
0
|
3
|
1
|
|
Resected
|
1
|
0
|
2
|
|
Median
no. of months from diagnosis to study entry (range)
|
41
(2-110)
|
75
(3-136)
|
18
(2-202)
|
|
No.
of patients with prior therapy:
|
Surgery
|
9
|
10
|
8
|
Radiotherapy
|
3
|
3
|
3
|
Chemotherapy
|
2
|
2
|
0
|
Tamoxifen
|
0
|
2
|
0
|
Immunotherapy
|
4
|
4
|
1
|
|
No.
of patients completing protocol
|
6
|
6
|
7
|
|
Reasons
for non-completion:
|
Disease
progression
|
3
|
2
|
1
|
Treatment
delay
|
0
|
2
|
0
|
|
|
|
|
|
|
Copyright
© 2004 by Jonathan Cebon